Tarsus Pharmaceuticals (TARS) EBT (2019 - 2026)
Tarsus Pharmaceuticals' (TARS) quarterly EBT came in at -$4.5 million in Q1 2026, up 81.92% year-on-year from -$2.5 million in Q1 2025, and up 27.44% quarter-over-quarter from -$6.2 million in Q4 2025.
Tarsus Pharmaceuticals (TARS) EBT (2019 - 2026) Analysis & Trends
Tarsus Pharmaceuticals' EBT history runs 8 years deep, the most recent figure standing at -$4.5 million for Q1 2026.
- On a quarterly basis, EBT rose 81.92% year-over-year to -$4.5 million in Q1 2026; TTM through Mar 2026 was -$147.1 million, a 42.94% decrease from a year earlier, with the FY2025 full-year figure at -$64.4 million, up 44.3% from the prior year.
- EBT grew to -$4.5 million in Q1 2026 per TARS's latest filing, from -$6.2 million in the prior quarter.
- Across five years, EBT topped out at -$4.5 million in Q1 2026 and bottomed at -$123.7 million in Q2 2025.
- The 5-year median for EBT is -$23.3 million (2023), against an average of -$28.4 million.
- Across the five-year window, EBT slumped 474.12% in 2023 and soared 81.92% in 2026, its largest moves.
- Year by year, EBT stood at -$13.1 million in 2022, then plunged by 224.08% to -$42.5 million in 2023, then jumped by 45.51% to -$23.1 million in 2024, then jumped by 73.03% to -$6.2 million in 2025, then rose by 27.44% to -$4.5 million in 2026.
- Per Business Quant, the three latest TARS EBT figures stand at -$4.5 million (Q1 2026), -$6.2 million (Q4 2025), and -$12.7 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Tarsus Pharmaceuticals | 2.52 Bn | 2.41 Bn | 152.66 Mn | -4.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.53 Mn |
| Dec 31, 2025 | -6.24 Mn |
| Sep 30, 2025 | -12.68 Mn |
| Jun 30, 2025 | -123.69 Mn |
| Mar 31, 2025 | -25.04 Mn |
| Dec 31, 2024 | -23.14 Mn |
| Sep 30, 2024 | -23.49 Mn |
| Jun 30, 2024 | -31.28 Mn |
| Mar 31, 2024 | -35.55 Mn |
| Dec 31, 2023 | -42.46 Mn |
| Sep 30, 2023 | -38.95 Mn |
| Jun 30, 2023 | -31.41 Mn |
| Mar 31, 2023 | -23.34 Mn |
| Dec 31, 2022 | -13.10 Mn |
| Sep 30, 2022 | -22.48 Mn |
| Jun 30, 2022 | -5.47 Mn |
| Mar 31, 2022 | -19.84 Mn |
| Dec 31, 2021 | -14.45 Mn |
| Sep 30, 2021 | -15.70 Mn |
| Jun 30, 2021 | 7.20 Mn |